IDiyas

For the Inventor, By the Inventor

Fairfield, CT, United States of America

Stephen Boyer

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 8.4

ph-index = 6

Forward Citations = 68(Granted Patents)


Location History:

  • Fairfield, CT (US) (2004 - 2011)
  • Hilden, DE (2005 - 2014)

Company Filing History:

goldMedal6 out of 780 
 
Bayer Healthcare LLC
 patents
silverMedal5 out of 70 
 
Bayer Pharmaceuticals Corporation
 patents

Years Active: 2004-2014

Loading Chart...
Loading Chart...
11 patents (USPTO):
1. 8637553 - Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions (2014-01-28),
2. 8076488 - Bicyclic urea derivatives useful in the treatment of cancer and other disorders (2011-12-13),
3. 7977333 - Substituted pyridines and pyridazines with angiogenesis inhibiting activity (2011-07-12),
4. 7928227 - 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders (2011-04-19),
5. 7645878 - Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof (2010-01-12),
6. 7557129 - Cyanopyridine derivatives useful in the treatment of cancer and other disorders (2009-07-07),
7. 6943172 - Rho-kinase inhibitors (2005-09-13),
8. 6930114 - Pyrrolo (2.1a)dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors (2005-08-16),
9. 6924290 - Rho-kinase inhibitors (2005-08-02),
10. 6903101 - Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity (2005-06-07),
11. 6689883 - Substituted pyridines and pyridazines with angiogenesis inhibiting activity (2004-02-10),

Title: The Innovative Contributions of Stephen Boyer

Introduction

Stephen Boyer is a notable inventor based in Fairfield, CT, who has made significant contributions to the field of pharmaceuticals. With a total of 11 patents to his name, Boyer has focused on developing compounds that address critical health issues.

Latest Patents

Among his latest patents, Boyer has developed a compound known as fluoro substituted omega-carboxyaryl diphenyl urea. This compound is designed for the treatment and prevention of diseases mediated by various receptors, including raf, VEGFR, PDGFR, p38, and flt-3. Another significant invention is related to bicyclic urea derivatives, which are useful in treating cancer and other disorders. This invention encompasses novel diaryl ureas and pharmaceutical compositions that can be used either as a sole agent or in combination with cytotoxic therapies to treat hyper-proliferative and angiogenesis disorders.

Career Highlights

Boyer has worked with prominent companies in the pharmaceutical industry, including Bayer Healthcare LLC and Bayer Pharmaceuticals Corporation. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field.

Collaborations

Throughout his career, Boyer has collaborated with esteemed colleagues such as Jacques P. Dumas and Wendy Lee. These partnerships have further enhanced his innovative capabilities and expanded the impact of his work.

Conclusion

Stephen Boyer is a distinguished inventor whose work in pharmaceuticals has led to the development of important compounds for treating various diseases. His contributions continue to influence the medical field and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…